Artivion | CRY - Assets


Artivion reported $883.16M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 883.16M 1.64M Mar/2026
AtriCure USD 643.99M 10.19M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Integra LifeSciences USD 3.58B 24.28M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 886.6M 35.95M Mar/2026
Pfizer USD 207.62B 542M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Terumo JPY 2.31T 55.3B Mar/2026
Trinity Biotech USD 105.16M 1.45M Dec/2025